rs13026650

Positions:

• chr2-147916632-G-A
• chr2-147916632-G-C
• chr2-147916632-G-T

Variant summary

Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_Strong BA1

The NM_001616.5(ACVR2A):​c.673-651G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.325 in 151,510 control chromosomes in the GnomAD database, including 8,270 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

• Frequency: Genomes: 𝑓 0.33 (8270 hom., cov: 31)
• Consequence: ACVR2A NM_001616.5 intron
• Clinical Significance: Not reported in ClinVar
• Conservation: PhyloP100: 2.07

Genes affected

ACVR2A (HGNC:173): (activin A receptor type 2A) This gene encodes a receptor that mediates the functions of activins, which are members of the transforming growth factor-beta (TGF-beta) superfamily involved in diverse biological processes. The encoded protein is a transmembrane serine-threonine kinase receptor which mediates signaling by forming heterodimeric complexes with various combinations of type I and type II receptors and ligands in a cell-specific manner. The encoded type II receptor is primarily involved in ligand-binding and includes an extracellular ligand-binding domain, a transmembrane domain and a cytoplasmic serine-threonine kinase domain. This gene may be associated with susceptibility to preeclampsia, a pregnancy-related disease which can result in maternal and fetal morbidity and mortality. Alternative splicing results in multiple transcript variants of this gene. [provided by RefSeq, Jun 2013]

ACMG classification

Verdict is Benign. Variant got -12 ACMG points.

• BP4: Computational evidence support a benign effect (BayesDel_noAF=-0.82).
• BA1: GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.496 is higher than 0.05.

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	#exon/exons	MANE	Protein	UniProt
ACVR2A	NM_001616.5	c.673-651G>A		intron_variant		ENST00000241416.12	NP_001607.1
ACVR2A	NM_001278579.2	c.673-651G>A		intron_variant			NP_001265508.1
ACVR2A	NM_001278580.2	c.349-651G>A		intron_variant			NP_001265509.1
ACVR2A	XM_047446292.1	c.349-651G>A		intron_variant			XP_047302248.1

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	#exon/exons	TSL	MANE	Protein	Appris	UniProt
ACVR2A	ENST00000241416.12	c.673-651G>A		intron_variant		1	NM_001616.5	ENSP00000241416	P1
ACVR2A	ENST00000404590.1	c.673-651G>A		intron_variant		1		ENSP00000384338	P1
ACVR2A	ENST00000535787.5	c.349-651G>A		intron_variant		2		ENSP00000439988

Frequencies

GnomAD3 genomes AF: 0.325 AC: 49259 AN: 151390 Hom.: 8265 Cov.: 31

Gnomad AFR AF: 0.298

Gnomad AMI AF: 0.273

Gnomad AMR AF: 0.382

Gnomad ASJ AF: 0.328

Gnomad EAS AF: 0.512

Gnomad SAS AF: 0.314

Gnomad FIN AF: 0.335

Gnomad MID AF: 0.415

Gnomad NFE AF: 0.314

Gnomad OTH AF: 0.349

We have no GnomAD4 exomes data on this position. Probably position not covered by the project.

GnomAD4 genome AF: 0.325 AC: 49308 AN: 151510 Hom.: 8270 Cov.: 31 AF XY: 0.327 AC XY: 24227 AN XY: 74008

Gnomad4 AFR AF: 0.298

Gnomad4 AMR AF: 0.382

Gnomad4 ASJ AF: 0.328

Gnomad4 EAS AF: 0.512

Gnomad4 SAS AF: 0.313

Gnomad4 FIN AF: 0.335

Gnomad4 NFE AF: 0.314

Gnomad4 OTH AF: 0.348

Alfa AF: 0.181 Hom.: 365

Bravo AF: 0.333

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name	Calibrated prediction	Score	Prediction
BayesDel_noAF	Benign	-0.82
CADD	Benign	5.5
DANN	Benign	0.57

Splicing

Name	Calibrated prediction	Score	Prediction
SpliceAI score (max)		0.0		Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Other links and lift over

dbSNP: rs13026650; hg19: chr2-148674201;